Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Burjeel HoldingsADX:BURJEEL -3.60%79 ROE % is 9.36% as of Mar. 2026, which is 76% below its 10-year median of 39.73. GuruFocus rates ADX:BURJEEL with a GF Score™ of 79/100 and a GF Value™ of د.إ2.54 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 623 Healthcare Providers & Services companies, Burjeel Holdings ranks better than 88.76% on this metric.
The historical rank and industry rank for Burjeel Holdings's ROE % or its related term are showing as below:
ADX:BURJEEL'
s ROE % Range Over the Past 10 Years
Min: 21.05 Med: 39.73 Max: 60.79
Current: 24.8
During the past 7 years, Burjeel Holdings's highest ROE % was 60.79%. The lowest was 21.05%. And the median was 39.73%.
ADX:BURJEEL's ROE % is ranked better than 88.76% of 623
companies
in the Healthcare Providers & Services industry
Industry Median: 5.88
vs ADX:BURJEEL: 24.80
Burjeel Holdings (ADX:BURJEEL) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Burjeel Holdings ROE % Related Terms
Burjeel Holdings ROE % Historical Data
* Premium members only.
The historical data trend for Burjeel Holdings's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Burjeel Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burjeel Holdings ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Burjeel Holdings's ROE % distribution charts can be found below:
* The bar in red indicates where Burjeel Holdings's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Burjeel Holdings (ADX:BURJEEL) has a ROE % of 9.36% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Burjeel Holdings and its competitors. This is 76% below median its historical median of 39.73. Over the past decade, Burjeel Holdings' ROE % has ranged from 21.05 to 60.79. According to the industry distribution chart, Burjeel Holdings ranks #70 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 11.2%.
Is Burjeel Holdings' ROE % too high?
Burjeel Holdings' current ROE % of 9.36% is 76% below median its 10-year median of 39.73. Over the past 10 years, this metric has ranged from a low of 21.05 to a high of 60.79. The Healthcare Providers & Services industry median ROE % is 5.88. Burjeel Holdings' value of 9.36% is 59.2% above this industry median. Based on the distribution chart, Burjeel Holdings ranks #70 out of 623 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Burjeel Holdings has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Burjeel Holdings' ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Burjeel Holdings ranks #70 out of 623 companies for ROE %. This places Burjeel Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median ROE % is 5.88. Burjeel Holdings' value of 9.36% is 59.2% above this benchmark. Historically, Burjeel Holdings' own ROE % has ranged from 21.05 to 60.79 over the past decade. While the company's 10-year median is 39.73 vs. the industry median of 5.88, Burjeel Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Burjeel Holdings's current ROE % of 9.36% is 59.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Burjeel Holdings and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Burjeel Holdings's current ROE % is 9.36%, which is 76% below median its own 10-year median of 39.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burjeel Holdings stock overvalued right now?
Based on GuruFocus' analysis, Burjeel Holdings (ADX:BURJEEL) is currently considered Significantly Undervalued. The stock's GF Value™ is د.إ2.54, compared to a current price of د.إ1.07 — trading 57.9% below its estimated fair value. The current ROE % is 9.36%, which is 76% below median its 10-year median of 39.73 and 59.2% above the Healthcare Providers & Services industry median of 5.88. Burjeel Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Burjeel Holdings (ADX:BURJEEL), the current ROE % is 9.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Burjeel Holdings (ADX:BURJEEL) Overvalued in 2026?
Based on GuruFocus' analysis, Burjeel Holdings stock appears to be undervalued.
The current stock price of د.إ1.07 is trading 57.9% below its estimated GF Value™ of د.إ2.54.
GuruFocus considers Burjeel Holdings to be Significantly Undervalued.
Key valuation signals for ADX:BURJEEL:
ROE %: 9.36% (76% below median its 10-year median of 39.73)
GF Value™: د.إ2.54 vs. price of د.إ1.07 (57.9% below fair value)
Industry Position: 59.2% above the Healthcare Providers & Services median (#70 of 623)
No single metric tells the full story. See the ADX:BURJEEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Burjeel Holdings PLC is a healthcare service provider. Along with its subsidiaries, it provides multi-specialty hospitals, medical, surgical and dental services, and the sale of pharmaceutical goods and medical equipment. The group's reportable segments are Hospitals, Medical Centre, Pharmacies, and Others. Maximum revenue for the group is derived from the Hospitals segment, which includes entities that provide inpatient, day-care services, and outpatient services to patients to diagnosis the disease and offer medical and surgical treatment as part of in-patient services. Geographically it derives maximum revenue from its customers in the United Arab Emirates, followed by the Sultanate of Oman and the Kingdom of Saudi Arabia.
79GF Score
Get the complete analysis for ADX:BURJEEL
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:BURJEEL has been successfully added to your 
